Fig. 2From: Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancerSomatic gene alterations associated with baseline patients. a The genomic landscape of MET TKD mutation-positive baseline patients (N = 32). Each column represents one patient. The frequency of each gene alteration is listed on the left. b The bar graph demonstrates the number of baseline patients who harbor MET TKD mutations but no previously reported oncogenic driver alterationsBack to article page